Cannabis Modulation of Outcomes Related to Opioid Use Disorder: Opioid Withdrawal, Abuse Potential and Safety
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1
SUMMARY
This study plans to enroll participants with opioid use disorder who are not currently seeking treatment to assess the effects of cannabis on opioid withdrawal and other related outcomes.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 55
Healthy Volunteers: t
View:
• Current opioid use disorder
Locations
United States
Kentucky
Center on Drug and Alcohol Research
RECRUITING
Lexington
Contact Information
Primary
Paul Nuzzo, MA
pnuzz2@email.uky.edu
859-323-0002
Time Frame
Start Date: 2024-09-10
Estimated Completion Date: 2027-06-30
Participants
Target number of participants: 15
Treatments
Experimental: Intranasal Opioid Agonist
Participants will receive non-therapeutic, experimental doses of an opioid agonist or placebo. Active opioid agonist/placebo will be administered once per session and will be administered intransally (snorting).
Experimental: Vaporized cannabis
Participants will receive non-therapeutic, experimental doses of active or placebo vaporized cannabis. Active cannabis/placebo will be administered once per session and will be administered via a vaporizer.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute on Drug Abuse (NIDA)
Leads: University of Kentucky